Search

Your search keyword '"Nativi‐Nicolau, Jose"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Nativi‐Nicolau, Jose" Remove constraint Author: "Nativi‐Nicolau, Jose"
149 results on '"Nativi‐Nicolau, Jose"'

Search Results

103. Cardiogenic Shock and Short-Term Mechanical Circulatory Support Options in the Current Era: Focus on Adverse Events

104. Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction

105. Utilization and Impact of Right Heart Catheterization on In-hospital Mortality, Length of hospital Stay and 30 Day Readmission in Patients Admitted with Cardiogenic Shock - Review of Large, National, Multicenter Database

106. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging

108. Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support

109. CONTINUOUS WEARABLE MONITORING ANALYTICS PREDICT HEART FAILURE DECOMPENSATION: THE LINK-HF MULTI-CENTER STUDY

112. Real-Time Assessment of Patient Reported Outcomes in Heart Failure Clinic

114. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure)

115. Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant

116. Amyloidosis Cardiomyopathy Demonstrates Distinct Echocardiographic Patterns Compared to Patients with Heart Failure with Preserved Ejection Fraction

117. Automated Heart Failure Quality Measurement with Natural Language Processing

118. FEASIBILITY AND EFFECTIVENESS OF A MULTIDISCIPLINARY TEAM APPROACH IN REFRACTORY CARDIOGENIC SHOCK: A PROSPECTIVE PILOT STUDY

119. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis

120. Cardiac Rotational Mechanics as a Predictor of Favorable Functional and Structural Response After Mechanical Unloading With Cardiac Assist Devices in Advanced Heart Failure Patients

121. Galectin-3 in Heart Failure With Preserved Ejection Fraction

122. Diagnostic Tools for Cardiac Amyloidosis: A Pragmatic Comparison of Pathology, Imaging and Laboratories.

124. Determinants of Waiting List Time for Heart Transplantation: Is It All About Sensitization?

128. Decreased Myocardial Inflammatory Markers in the Failing Human Heart after Continuous Flow Left Ventricular Assist Device-Induced Mechanical Unloading

129. Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy

130. Abstract 12264: Insurance Type is Associated With Health-related Quality of Life in Heart Failure

131. Abstract 14637: Demographic Characteristics of Medicare Beneficiaries With Diagnosis of Wild-Type Amyloidosis Cardiomyopathy

134. Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy.

135. Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression.

136. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.

137. Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.

138. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.

139. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices.

140. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

142. Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review.

143. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

144. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.

145. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.

146. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.

147. Utility of Biomarkers in Cardiac Amyloidosis.

148. Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices.

149. Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction.

Catalog

Books, media, physical & digital resources